View of Plant-Derived DPP-4 Inhibitors in Cardiometabolic Diseases: A Critical Evaluation of the Evidence Base and Priorities for Kazakhstan

Return to Article Details Plant-Derived DPP-4 Inhibitors in Cardiometabolic Diseases: A Critical Evaluation of the Evidence Base and Priorities for Kazakhstan Download Download PDF